Latest news
Piramal Pharma eyes U.S. manufacturing opportunities, forecasts return to profit in coming quarters - CNBCCNBC · Fri, 31 Jul 2026 07:00:00 GMTPiramal Pharma to focus on policy, not Trump tariff tweets: Nandini Piramal - The Economic TimesThe Economic Times · Fri, 31 Jul 2026 07:00:00 GMTPiramal Pharma seeing broad-based revival in CDMO, complex generics, says Nandini Piramal - TradingViewTradingView · Fri, 31 Jul 2026 05:07:00 GMT‘Remain agile’ to manage costs in an uncertain global environment: Nandini Piramal - BusinessLineBusinessLine · Thu, 30 Jul 2026 07:00:00 GMTPiramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion - Business StandardBusiness Standard · Thu, 30 Jul 2026 07:00:00 GMTPiramal Pharma shareholders approve NCDs and director reappointments - scanx.tradescanx.trade · Thu, 30 Jul 2026 07:00:00 GMTPiramal Pharma Limited Announces Results for Q1 FY27 - PR Newswire CanadaPR Newswire Canada · Wed, 29 Jul 2026 19:27:00 GMT